CHI3L1 and relapsing-remitting multiple sclerosis: Fino et al. demonstrated significantly higher CSF CHI3L1 levels in CIS and RRMS patients than in controls [55], suggesting the involvement of CHL3L1 in the pathogenesis of MS.